0.0550USD0.00%Mkt Cap: —P/E: —Last update: 2026-06-11
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The compa…
Industry Peers
Biotechnology112.95BUSDP/E 26.4
99.40BDKKP/E 19.0
64.11BUSDP/E 14.9
52.33BEURP/E 34.3
48.73BEURP/E 40.1
37.76BUSDP/E 70.9
32.08BSEKP/E 47.5
31.84BUSDP/E 29.1
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)545.76M USD
Gross Profit76.44M USD
Net Income (TTM)-60.61M USD
Revenue/Share5.537 USD
Last Price0.0550 USD
Fiscal Year End—
MR Quarter—
Employees641
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.29
EPS (TTM)-602.09
EPS (Forward)—
52W Range
0.0470100% of range0.0550
52W High0.0550 USD
52W Low0.0470 USD
Profitability
Gross Margin15.20%
Oper. Margin-4.42%
EBITDA Margin-4.75%
Profit Margin-12.06%
ROE385.53%
ROA-36.81%
Growth
Revenue Growth41.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.59M USD
CapEx (TTM)3.20M USD
FCF Margin-2.81%
FCF Yield—
Net Debt74.63M USD
Net Debt/EBITDA-2.88
Balance Sheet
Debt/Equity-6.60
Current Ratio1.47
Quick Ratio1.13
Book Value/Sh-0.1630 USD
Cash/Share0.3030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float87.33M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.41
S&P 52W Chg23.71%
Avg Vol (30d)0
Avg Vol (10d)—
Technical Indicators
RSI (14)100.0
MACD0.0001
MACD Signal0.0002
MACD Hist.-0.0001
BB Upper0.0550 USD
BB Middle0.0550 USD
BB Lower0.0550 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—